ATLAS / Macro Radar / Reporting / TBPH

Theravance Biopharma, Inc. (TBPH) reporting calendar

Theravance Biopharma, Inc. files periodic reports with the SEC as TBPH on Nasdaq. Atlas tracks 45 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
21 Jul 2026 – 3 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
45

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open TBPH market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001104659-26-056760
10-K31 Dec 202523 Mar 202682 days0001104659-26-033077
10-Q30 Sep 202512 Nov 202543 days0001104659-25-110382
10-Q30 Jun 202513 Aug 202544 days0001558370-25-011408
10-Q31 Mar 202512 May 202542 days0001558370-25-007398
10-K31 Dec 20247 Mar 202566 days0001558370-25-002447
10-Q30 Sep 202414 Nov 202445 days0001558370-24-015602
10-Q30 Jun 20248 Aug 202439 days0001558370-24-011636
10-Q31 Mar 202415 May 202445 days0001558370-24-008201
10-K31 Dec 20231 Mar 202461 days0001558370-24-002267
10-Q30 Sep 20239 Nov 202340 days0001558370-23-018612
10-Q30 Jun 20239 Aug 202340 days0001558370-23-014070
10-Q31 Mar 202310 May 202340 days0001558370-23-008951
10-K31 Dec 20221 Mar 202360 days0001558370-23-002595
10-Q30 Sep 20229 Nov 202240 days0001558370-22-017048
10-Q30 Jun 20228 Aug 202239 days0001558370-22-012666
10-Q31 Mar 20226 May 202236 days0001558370-22-007651
10-K31 Dec 202128 Feb 202259 days0001558370-22-002373
10-Q30 Sep 20218 Nov 202139 days0001558370-21-014907
10-Q30 Jun 20215 Aug 202136 days0001558370-21-010555
10-Q31 Mar 20216 May 202136 days0001558370-21-006234
10-K31 Dec 202026 Feb 202157 days0001558370-21-002006
10-Q30 Sep 20209 Nov 202040 days0001558370-20-013233
10-Q30 Jun 202010 Aug 202041 days0001558370-20-010023
10-Q31 Mar 20208 May 202038 days0001558370-20-006021
10-K31 Dec 201927 Feb 202058 days0001558370-20-001644
10-Q30 Sep 20198 Nov 201939 days0001558370-19-010487
10-Q30 Jun 20195 Aug 201936 days0001558370-19-007084
10-Q31 Mar 201910 May 201940 days0001558370-19-004767
10-K31 Dec 201828 Feb 201959 days0001558370-19-001346
10-Q30 Sep 20188 Nov 201839 days0001558370-18-008888
10-Q30 Jun 20182 Aug 201833 days0001558370-18-006147
10-Q31 Mar 20189 May 201839 days0001558370-18-004404
10-K31 Dec 201728 Feb 201859 days0001047469-18-001160
10-Q30 Sep 20178 Nov 201739 days0001104659-17-066731
10-Q30 Jun 20179 Aug 201740 days0001104659-17-050414
10-Q31 Mar 201710 May 201740 days0001104659-17-031264
10-K31 Dec 20161 Mar 201760 days0001047469-17-001086
10-Q30 Sep 20169 Nov 201640 days0001104659-16-155621
10-Q30 Jun 20169 Aug 201640 days0001104659-16-138040

Source: SEC EDGAR company submissions for CIK 0001583107. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.